Objectives: Community-acquired pneumonia (CAP) poses a significant risk of complications in cancer patients. However, limited studies have evaluated hospitalised cancer patients with CAP. This study aimed to evaluate the characteristics and outcomes of cancer patients hospitalised with CAP. Methods: This retrospective …
Mycoplasma pneumoniae is a common cause of community-acquired pneumonia. As M. pneumoniae pneumonia is usually a mild and self-limiting disease, complications such as pleural effusion occur only rarely. We report a 22-year-old woman who presented to the Emergency Medicine Department of the Sultan Qaboos University Hosp …
… on of an early percutaneous dilatational tracheostomy (PDT) in a 61-year-old male with severe ARDS due to community-acquired pneumonia (CAP)-induced sepsis and type I respiratory failure. This case suggests that early PDT is a safe and effective way to reduce the risks of prolonged mechanical ventilation in severe ARDS …
… by amoxicillin/clavulanic acid and clarithromycin. Antimicrobial agents were predominantly prescribed for community-acquired pneumonia followed by urinary tract infection. Microbiological cultures were obtained from only 25% of patients prior to initiating antimicrobial therapy. The most common isolated organisms were …
… es. The patient’s blood and bronchoalveolar lavage cultures were negative. He was diagnosed with atypical community-acquired pneumonia (CAP) and discharged on a course of azithromycin. The patient was lost to follow-up until he presented to our hospital four months later with constitutional symptoms. He reported night …